compounded semaglutide fda shortage says of weight loss drug over, compounders nervous 🚨 FDA Moves to Permanently

Your healthcare provider will assess your progress and help determine how long you should stay on semaglutide

This was a landmark study that showed a weight-loss drug could protect the heart even in people who did not have diabetes

After 40, tendons and connective tissue recover slower than muscle

Compared to the native hormones, retatrutide shows 2.9-fold less potency at the glucagon receptor (GCCR), 2.5-fold less potency at the GLP-1 receptor, and 8.9-fold greater potency at human GIP receptor [1]

Dual agonist mechanisms may offer better tolerability and potentially fewer side effects due to more focused receptor targeting, while still providing significant weight loss benefits through synergistic pathways

Thats why the slow, steady dose increases were so reassuring